1. Home
  2. Knowledge Base
  3. References
  4. Chlorotoxin conjugated with saporin reduces viability of ML-1 thyroid cancer cells in vitro.

Chlorotoxin conjugated with saporin reduces viability of ML-1 thyroid cancer cells in vitro.

Rizvanovic H, Pinheiro AD, Kim K, Thomas J (2019) Chlorotoxin conjugated with saporin reduces viability of ML-1 thyroid cancer cells in vitro. bioRxiv 885483. doi: 10.1101/2019.12.20.885483

Objective: To determine whether Chlorotoxin-conjugated Saporin (CTX-SAP) would inhibit the growth of aggressive thyroid cancer cell lines expressing MMP-2.

Summary: This in vitro study demonstrated the efficacy of a CTX-SAP conjugate in reducing the viability of ML-1 thyroid cancer cells in a dose dependent manner.

Usage: There was a statistically significant reduction in cell viability with increasing concentrations of the CTX-SAP conjugate (biotinylated Chlorotoxin mixed with Streptavidin-ZAP). The cell viability of ML-1 cells was decreased by 49.77% with the treatment of 600 nM of CTX-SAP (F=44.24). Unconjugated Chlorotoxin or Saporin had no significant effect on cell viability a using similar assay.

Related Products: Streptavidin-ZAP (Cat. #IT-27), Saporin (Cat. #PR-01), Chlorotoxin-SAP (Cat. #IT-86)

Shopping Cart
Scroll to Top